[Federal Register Volume 67, Number 152 (Wednesday, August 7, 2002)]
[Notices]
[Page 51287]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-19870]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), announcement is made of the 
following National Advisory body scheduled to meet during the month of 
September.

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: September 4, 2002; 9:00 a.m.-12:30 p.m.
    Place: Audio Conference Call.
    The full ACCV will meet via audio conference call on Wednesday, 
September 4, from 9:00 a.m. to 12:30 p.m. The public can join the 
meeting by dialing 1-888-968-3511 on September 4 and provide the 
following information:
    Leader's Name: Thomas E. Balbier, Jr.
    Password: ACCV.
    The agenda items for September 4 will include, but not limited 
to: an update on the thimerosal class action lawsuits; an update on 
the CDC influenza vaccine recommendation; a presentation on the 
average cost of a health insurance policy; and updates from the 
Division of Vaccine Injury Compensation, the Department of Justice, 
and the National Vaccine Program Office.
    Persons interested in providing an oral presentation should 
submit a written request, along with a copy of their presentation 
to: Ms. Cheryl Lee, Principal Staff Liaison, Division of Vaccine 
Injury Compensation, Office of Special Programs, Health Resources 
and Services Administration, Room 8A-46, 5600 Fishers Lane, 
Rockville, MD 20857 or by e-mail at [email protected]. Requests should 
contain the name, address, telephone number, and any business or 
professional affiliation of the person desiring to make an oral 
presentation. Groups having similar interests are requested to 
combine their comments and present them through a single 
representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. The Division of Vaccine 
Injury Compensation will notify each presenter by mail or telephone 
of their assigned presentation time.
    Persons who do not file an advance request for a presentation, 
but desire to make an oral statement, may announce it at the time of 
the comment period on the audio conference call. These persons will 
be allocated time as time permits.
    Anyone requiring information regarding the ACCV should contact 
Ms. Cheryl Lee, Principal Staff Liaison, Division of Vaccine Injury 
Compensation, Office of Special Programs, Health Resources and 
Services Administration, Room 8A-46, 5600 Fishers Lane, Rockville, 
Maryland 20857, telephone (301) 443-2124 or e-mail: [email protected].
    Agenda items are subject to change as priorities dictate.

    Dated: July 31, 2002.
Jane M. Harrison,
Director, Division of Policy Review and Coordination.
[FR Doc. 02-19870 Filed 8-6-02; 8:45 am]
BILLING CODE 4165-15-P